{"count": 9, "results": [{"_id": "33617679", "pmid": 33617679, "title": "The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial.", "journal": "Int J Clin Pract", "authors": ["Abdel Monem MS", "Farid SF", "Abbassi MM", "Youssry I", "Andraues NG", "Hassany M", "Selim YMM", "El-Sayed MH"], "date": "2021-06-01T00:00:00Z", "doi": "10.1111/ijcp.14104", "meta_date_publication": "2021 Jun", "meta_volume": "75", "meta_issue": "6", "meta_pages": "e14104", "score": 50253.094, "text_hl": "The potential hepatoprotective effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@hepatitis C virus-infected@@@ adolescent @SPECIES_9606 @@@patients@@@ with @DISEASE_beta_Thalassemia @DISEASE_MESH:D017086 @@@beta thalassemia major@@@: Randomised clinical trial.", "citations": {"NLM": "Abdel Monem MS, Farid SF, Abbassi MM, Youssry I, Andraues NG, Hassany M, Selim YMM, El-Sayed MH. The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial. Int J Clin Pract. 2021 Jun;75(6):e14104. PMID: 33617679", "BibTeX": "@article{33617679, title={The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial.}, author={Abdel Monem MS and Farid SF and Abbassi MM and Youssry I and Andraues NG and Hassany M and Selim YMM and El-Sayed MH}, journal={Int J Clin Pract}, volume={75}, number={6}, pages={e14104}}"}}, {"_id": "33918222", "pmid": 33918222, "pmcid": "PMC8065725", "title": "Additional Inhibition of Wnt/beta-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients", "journal": "Cells", "authors": ["Lin D", "Reddy V", "Osman H", "Lopez A", "Koksal AR", "Rhadhi SM", "Dash S", "Aydin Y"], "date": "2021-04-02T00:00:00Z", "doi": "10.3390/cells10040790", "meta_date_publication": "2021 Apr 2", "meta_volume": "10", "meta_issue": "4", "meta_pages": "", "score": 50251.74, "text_hl": "...2.8. @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@HCV@@@ Eradication and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Treatment", "citations": {"NLM": "Lin D, Reddy V, Osman H, Lopez A, Koksal AR, Rhadhi SM, Dash S, Aydin Y. Additional Inhibition of Wnt/beta-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients Cells. 2021 Apr 2;10(4):. PMID: 33918222", "BibTeX": "@article{33918222, title={Additional Inhibition of Wnt/beta-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients}, author={Lin D and Reddy V and Osman H and Lopez A and Koksal AR and Rhadhi SM and Dash S and Aydin Y}, journal={Cells}, volume={10}, number={4}}"}}, {"_id": "29385181", "pmid": 29385181, "pmcid": "PMC5791999", "title": "Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy", "journal": "PLoS One", "authors": ["Del Campo JA", "García-Valdecasas M", "Gil-Gómez A", "Rojas Á", "Gallego P", "Ampuero J", "Gallego-Durán R", "Pastor H", "Grande L", "Padillo FJ", "Muntané J", "Romero-Gómez M"], "date": "2018-01-31T00:00:00Z", "doi": "10.1371/journal.pone.0191805", "meta_date_publication": "2018", "meta_volume": "13", "meta_issue": "1", "meta_pages": "e0191805", "score": 50069.21, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ effects on @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@HCV infection@@@.", "citations": {"NLM": "Del Campo JA, García-Valdecasas M, Gil-Gómez A, Rojas Á, Gallego P, Ampuero J, Gallego-Durán R, Pastor H, Grande L, Padillo FJ, Muntané J, Romero-Gómez M. Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy PLoS One. 2018;13(1):e0191805. PMID: 29385181", "BibTeX": "@article{29385181, title={Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy}, author={Del Campo JA and García-Valdecasas M and Gil-Gómez A and Rojas Á and Gallego P and Ampuero J and Gallego-Durán R and Pastor H and Grande L and Padillo FJ and Muntané J and Romero-Gómez M}, journal={PLoS One}, volume={13}, number={1}, pages={e0191805}}"}}, {"_id": "24259699", "pmid": 24259699, "title": "Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C.", "journal": "Ann Pharmacother", "authors": ["Harris K", "Smith L"], "date": "2013-10-01T00:00:00Z", "doi": "10.1177/1060028013503108", "meta_date_publication": "2013 Oct", "meta_volume": "47", "meta_issue": "10", "meta_pages": "1348-52", "score": 50057.29, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ may provide benefit in the treatment of @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@HCV@@@ and in reducing the risk of @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@HCC@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ and @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@HCV@@@. ", "citations": {"NLM": "Harris K, Smith L. Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C. Ann Pharmacother. 2013 Oct;47(10):1348-52. PMID: 24259699", "BibTeX": "@article{24259699, title={Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C.}, author={Harris K and Smith L}, journal={Ann Pharmacother}, volume={47}, number={10}, pages={1348-52}}"}}, {"_id": "26441826", "pmid": 26441826, "pmcid": "PMC4568414", "title": "Diabetes and Hepatitis C: A Two-Way Association", "journal": "Front Endocrinol (Lausanne)", "authors": ["Hammerstad SS", "Grock SF", "Lee HJ", "Hasham A", "Sundaram N", "Tomer Y"], "date": "2015-09-14T00:00:00Z", "doi": "10.3389/fendo.2015.00134", "meta_date_publication": "2015", "meta_volume": "6", "meta_issue": "", "meta_pages": "134", "score": 50051.83, "text_hl": "It remains to be determined whether the new curative therapies for @DISEASE_Hepatitis_C_Chronic @DISEASE_MESH:D019698 @@@chronic hepatitis C@@@ will improve outcomes in @DISEASE_Hepatitis_C_Chronic @DISEASE_MESH:D019698 @@@diabetic hepatitis C@@@ @SPECIES_9606 @@@patients@@@, and conversely whether treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ will reduce complications from @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@hepatitis C virus infection@@@. ", "citations": {"NLM": "Hammerstad SS, Grock SF, Lee HJ, Hasham A, Sundaram N, Tomer Y. Diabetes and Hepatitis C: A Two-Way Association Front Endocrinol (Lausanne). 2015;6():134. PMID: 26441826", "BibTeX": "@article{26441826, title={Diabetes and Hepatitis C: A Two-Way Association}, author={Hammerstad SS and Grock SF and Lee HJ and Hasham A and Sundaram N and Tomer Y}, journal={Front Endocrinol (Lausanne)}, volume={6}, pages={134}}"}}, {"_id": "21895746", "pmid": 21895746, "title": "Inhibition of hepatitis C virus replication through adenosine monophosphate-activated protein kinase-dependent and -independent pathways.", "journal": "Microbiol Immunol", "authors": ["Nakashima K", "Takeuchi K", "Chihara K", "Hotta H", "Sada K"], "date": "2011-11-01T00:00:00Z", "doi": "10.1111/j.1348-0421.2011.00382.x", "meta_date_publication": "2011 Nov", "meta_volume": "55", "meta_issue": "11", "meta_pages": "774-82", "score": 50051.37, "text_hl": "In contrast, compound C induced further suppression of @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@HCV@@@ replication when the cells were cultured in low @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ concentrations or with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Nakashima K, Takeuchi K, Chihara K, Hotta H, Sada K. Inhibition of hepatitis C virus replication through adenosine monophosphate-activated protein kinase-dependent and -independent pathways. Microbiol Immunol. 2011 Nov;55(11):774-82. PMID: 21895746", "BibTeX": "@article{21895746, title={Inhibition of hepatitis C virus replication through adenosine monophosphate-activated protein kinase-dependent and -independent pathways.}, author={Nakashima K and Takeuchi K and Chihara K and Hotta H and Sada K}, journal={Microbiol Immunol}, volume={55}, number={11}, pages={774-82}}"}}, {"_id": "27439433", "pmid": 27439433, "pmcid": "PMC4955144", "title": "Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial", "journal": "Trials", "authors": ["Doyle MA", "Singer J", "Lee T", "Muir M", "Cooper C"], "date": "2016-07-20T00:00:00Z", "doi": "10.1186/s13063-016-1454-6", "meta_date_publication": "2016 Jul 20", "meta_volume": "17", "meta_issue": "1", "meta_pages": "331", "score": 50048.152, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has been studied in both @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@HCV@@@ and @DISEASE_HIV_Infections @DISEASE_MESH:D015658 @@@HIV mono-infected@@@ @SPECIES_9606 @@@patients@@@ with no increase in adverse events (AE). ", "citations": {"NLM": "Doyle MA, Singer J, Lee T, Muir M, Cooper C. Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial Trials. 2016 Jul 20;17(1):331. PMID: 27439433", "BibTeX": "@article{27439433, title={Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial}, author={Doyle MA and Singer J and Lee T and Muir M and Cooper C}, journal={Trials}, volume={17}, number={1}, pages={331}}"}}, {"_id": "28413215", "pmid": 28413215, "pmcid": "PMC5402856", "title": "Successful Withdrawal of Insulin Therapy After Post-Treatment Clearance of Hepatitis C Virus in a Man with Type 2 Diabetes", "journal": "Am J Case Rep", "authors": ["Davis TME", "Davis WA", "Jeffrey G"], "date": "2017-04-17T00:00:00Z", "doi": "10.12659/ajcr.903600", "meta_date_publication": "2017 Apr 17", "meta_volume": "18", "meta_issue": "", "meta_pages": "414-417", "score": 50039.03, "text_hl": "He was started on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ but progressed to multiple daily @GENE_INS @GENE_3630 @@@insulin@@@ injections after 3 years. ", "citations": {"NLM": "Davis TME, Davis WA, Jeffrey G. Successful Withdrawal of Insulin Therapy After Post-Treatment Clearance of Hepatitis C Virus in a Man with Type 2 Diabetes Am J Case Rep. 2017 Apr 17;18():414-417. PMID: 28413215", "BibTeX": "@article{28413215, title={Successful Withdrawal of Insulin Therapy After Post-Treatment Clearance of Hepatitis C Virus in a Man with Type 2 Diabetes}, author={Davis TME and Davis WA and Jeffrey G}, journal={Am J Case Rep}, volume={18}, pages={414-417}}"}}, {"_id": "24659880", "pmid": 24659880, "title": "Interaction between hepatitis C virus and metabolic factors.", "journal": "World J Gastroenterol", "authors": ["Kawaguchi Y", "Mizuta T"], "date": "2014-03-21T00:00:00Z", "doi": "10.3748/wjg.v20.i11.2888", "meta_date_publication": "2014 Mar 21", "meta_volume": "20", "meta_issue": "11", "meta_pages": "2888-901", "score": 50035.64, "text_hl": "While successful clinical management of @<m>DISEASE_Hepatitis_C</m> @DISEASE_MESH:D006526 @@@HCV-infected@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@metabolic disorders@@@ has also been achieved with some anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ (i.e., @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@) and anti-@CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ (i.e., statins) medications, it is recommended that @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylurea@@@ and @CHEMICAL_Insulin @CHEMICAL_MESH:D007328 @@@insulin@@@ be avoided. ", "citations": {"NLM": "Kawaguchi Y, Mizuta T. Interaction between hepatitis C virus and metabolic factors. World J Gastroenterol. 2014 Mar 21;20(11):2888-901. PMID: 24659880", "BibTeX": "@article{24659880, title={Interaction between hepatitis C virus and metabolic factors.}, author={Kawaguchi Y and Mizuta T}, journal={World J Gastroenterol}, volume={20}, number={11}, pages={2888-901}}"}}]}